TB-500 Administration Routes Comparison
Understanding the practical differences between administration routes clarifies why researchers and clinicians universally favor subcutaneous injection for TB-500. The table below compares bioavailability, onset characteristics, technical requirements, and pro
This comparison does not assign a generated winner or score.
- Understanding the practical differences between administration routes clarifies why researchers and clinicians universally favor subcutaneous injection for TB-500. The table below compares bioavailability, onset characteristics, technical requirements, and professional assessment across the primary routes.
- Subcutaneous Injection
- 80–95%
- 15–30 minutes, peak plasma at 2–4 hours
- Moderate. Requires sterile technique, bacteriostatic water reconstitution, insulin syringe
- Lyophilised powder stored −20°C; reconstituted solution refrigerated 2–8°C, use within 28 days
- Gold standard. Only route with documented systemic activity and peer-reviewed efficacy data
- Intravenous Injection
- ~100%
- Immediate, peak plasma within minutes
- High. Requires IV access, controlled infusion, medical oversight
- Same as subcutaneous
- Research/clinical setting only. Not practical for routine use, no bioavailability advantage over subcutaneous
- Oral Capsule/Tablet
- <2% (functionally zero)
- None. Degraded in stomach before absorption
- None. Consumer convenience
- Room temperature stable if encapsulated, no reconstitution
- Not viable. No detectable plasma levels, mechanism of action requires intact peptide in circulation
- Intranasal Spray
- 5–15% (unmodified peptides)
- 10–20 minutes if absorbed
- Low. Simple spray application
- Requires solution formulation, refrigeration recommended
- Marginal. Insufficient data for TB-500 specifically, absorption through nasal mucosa limited by molecular weight
- The comparison makes the issue clear: when you take TB-500 orally, you're not choosing a less efficient version of the same delivery. You're choosing a route that doesn't deliver the compound at all.